How many insider trades does FilingIQ track for CLDX?

FilingIQ tracks 213 Form 4 insider transactions for CLDX (Celldex Therapeutics, Inc.), covering filings from Jun 10, 2015 onwards. 0 of those were filed in the last 90 days.

Are CLDX insiders net buyers or net sellers?

Across the full Form 4 history for CLDX, 19 transactions (9%) were open-market purchases and 46 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CLDX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CLDX in?

Celldex Therapeutics, Inc. (CLDX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.63B.

CLDX insider trading

NasdaqCM Healthcare

Celldex Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

213

Last 90 days

Buys / sells

9% / 22%

Market cap

$1.63B

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.

Company website: www.celldex.com

CLDX insider activity at a glance

FilingIQ has scored 213 insider transactions for CLDX since Jun 10, 2015. The most recent filing in our index is dated Jan 2, 2026.

Across the full history, 19 open-market purchases and 46 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CLDX insider trades is 63.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CLDX trades on FilingIQ Raw filings on SEC EDGAR

Latest CLDX Form 4 filings

Martin Samuel Bates SVP AND CFO

S Jun 14, 2024

Martin Samuel Bates SVP AND CFO

S May 30, 2024

Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS

S May 30, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding CLDX

EVENTIDE ASSET MANAGEMENT, LLC

$143.97M · 2.3% of AUM

Sofinnova Investments, Inc.

$33.47M · 1.9% of AUM

VR Adviser, LLC

$23.32M · 4.6% of AUM

STEMPOINT CAPITAL LP

$5.35M · 1.6% of AUM

TFG Asset Management GP Ltd

$4.85M · 1.2% of AUM

Frequently asked

How many insider trades does FilingIQ track for CLDX?: FilingIQ tracks 213 Form 4 insider transactions for CLDX (Celldex Therapeutics, Inc.), covering filings from Jun 10, 2015 onwards. 0 of those were filed in the last 90 days.
Are CLDX insiders net buyers or net sellers?: Across the full Form 4 history for CLDX, 19 transactions (9%) were open-market purchases and 46 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CLDX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CLDX in?: Celldex Therapeutics, Inc. (CLDX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.63B.

Methodology & sources

Every CLDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.